Consun Pharmaceutical Proposes Share Award Scheme to Incentivize Staff; Shares Slip 2%

MT Newswires Live
Nov 07

Consun Pharmaceutical (HKG:1681) said its board has proposed adopting a new share award scheme to strengthen employee incentives and support long-term growth, according to a Thursday Hong Kong bourse filing.

Shares of the company fell 2% in late morning trade Friday.

The proposed scheme will enable Consun to grant share awards to employees, service providers, and related participants as part of a broader performance-based incentive framework.

It carries a mandate limit of 84.3 million shares, representing about 9.9% of the company's issued share capital, along with a service provider sublimit of 8.4 million shares, or about 1%, the filing said.

The plan, approved by the board on Nov. 6, will be put to shareholders for approval at an extraordinary general meeting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10